Adrenal insufficiency due to ritonavir-triamcinolone drug–drug interaction without preceding Cushing’s syndrome

0Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We present the case of a 58-year-old HIV-infected patient with adrenal insufficiency after local injection of triamcinolone, most likely due to drug–drug interaction with his ritonavir-boosted antiretroviral therapy (ART). This is the first case of adrenal insufficiency occurring without prior symptoms of Cushing’s syndrome in a patient on a booster-containing ART. We want to draw attention to this seemingly rare, but potentially life-threatening medical condition that can occur even in short-term use of glucocorticoids in low doses in patients on booster-containing ART and summarize some considerations for management.

Cite

CITATION STYLE

APA

Noe, S., Jaeger, H., & Heldwein, S. (2018). Adrenal insufficiency due to ritonavir-triamcinolone drug–drug interaction without preceding Cushing’s syndrome. International Journal of STD and AIDS, 29(11), 1136–1139. https://doi.org/10.1177/0956462418768689

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free